INmune Bio, Inc. is a clinical-stage immunotherapy company that develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs are INKmune, INB03, and XPro1595. INmune Bio, Inc. was founded in 2015 and is headquartered in Boca Raton, Florida.